Edition:
India

Eiger BioPharmaceuticals Inc (EIGR.OQ)

EIGR.OQ on NASDAQ Stock Exchange Global Market

11.29USD
12:16am IST
Change (% chg)

$-0.57 (-4.81%)
Prev Close
$11.86
Open
$11.89
Day's High
$11.89
Day's Low
$11.29
Volume
16,102
Avg. Vol
76,188
52-wk High
$15.30
52-wk Low
$8.51

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.897
FY 2018 Dec '18 0.00 -0.918
Sep '18 0.00 -1.203
Jun '18 0.00 -0.823
Mar '18 0.00 -0.839
FY 2017 Dec '17 0.00 -1.110
Sep '17 0.00 -1.095
Jun '17 0.00 -1.332
Mar '17 0.00 -1.344
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 4 0.00 0.00 0.00 16.67
Quarter Ending Dec-19 4 17.12 66.00 0.00 0.00
Year Ending Dec-19 5 13.70 66.00 0.00 8.92
Year Ending Dec-20 5 20.14 65.00 1.18 29.60
Earnings (per share)
Quarter Ending Sep-19 6 -0.75 -0.67 -0.87 0.07
Quarter Ending Dec-19 6 0.05 1.95 -0.87 -0.69
Year Ending Dec-19 6 -2.21 -0.07 -3.30 -2.67
Year Ending Dec-20 5 -2.29 -0.38 -3.45 -2.12
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 21.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Eiger BioPharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 5.57 2.63 75 --
13 Week 0.81 -2.05 69 --
26 Week -21.75 -31.09 34 --
52 Week 6.57 -0.06 74 --
YTD 10.14 -8.75 55 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 76.17%
# of Holders: 94
Total Shares Held: 18,612,153
3 Mo. Net Change: 2,855,079
# New Positions: 4
# Closed Positions: 1
# Increased Positions: 11
# Reduced Positions: 2
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.